References
- Lyon L, Fisch S, Nevins M, Henry S. Perhexiline Maleate in treatment of angina pectoris. Lancet 1971; 1: 1272–4
- Burns-Cox C J, Chandrasekhar K P, Ikram H, et al. Clinical evaluation of perhexiline maleate in patients with angina pectoris. Br Med J 1971; 4: 586–8
- Pilcher J, Chandrasekhar K P, Russell Rees J, et al. Long-term assessment of perhexiline maleate in angina pectoris. Postgrad Med J 1973; 115–8, (suppl 3)
- Newberne J W. Assessment of safety data from patients on short and long term perhexiline therapy. Postgrad Med J 1973; 125–9, (suppl 3)
- Howard D J, Russell Rees J. Long term perhexiline maleate and liver function. Br Med J 1976; 1: 133
- Kopelman P, Morgan P GM. Liver damage after perhexiline maleate. Lancet 1977; 1: 705
- Forbes G B, Rake M O, Taylor D JE. Liver damage due to perhexiline maleate. J Clin Pathol 1979; 32: 1282–5
- Pallard P, Vitrey D, Fournier G, et al. Perhexiline maleate-induced hepatitis. Digestion 1978; 17: 419–27
- Long J P, Maurer B J, Fitzgerald O. Hepatotoxicity following treatment with perhexiline maleate. Ir Med J 1980; 73: 275–6
- Lewis D, Wainwright H C, Kew M C, et al. Liver damage associated with perhexiline maleate. Gut 1979; 20: 186–9
- Pessayre D, Bichara M, Feldman G, et al. Perhexiline maleate-induced cirrhosis. Gastroenterology 1979; 76: 170–7
- Roberts R K, Cohn D, Petroff V, Seneviratne B. Liver disease induced by perhexiline maleate. Med J Aust 1981; 2: 553–4
- Feldman G. Hypoglycemia and perhexiline (Fr.). Nouv Presse Méd 1974; 3: 2580
- Houdent C E, Wolf L M, Corriat A. Liver during perhexiline hypoglycaemia. Lancet 1977; 2: 1028
- Caruzzo C, Gaschino G, Troni W, Cremo R. Toxic polyneuritis and toxic hepatitis related to long term perhexiline maleate therapy. Am Heart J 1980; 100: 270–1
- Lhermitte F, Fardeau M, Chedru F, Mallecourt J. Polyneuropathy after perhexiline maleate therapy. Br Med J 1976; 1: 1256
- Horowitz J D, Mashford M L. Long term safety of perhexiline maleate. Med J Aust 1979; 1: 232
- Tomlinson I W, Rosenthal F D. Proximal myopathy after perhexiline maleate therapy. Br Med J 1977; 1: 1319–20
- Atkinson A B, McAreavey D, Trope G. Papilledema and hepatic dysfunction apparently induced by perhexiline maleate (Pexid). Br Heart J 1980; 43: 490–1
- Maddrey W C, Boitnott J K. Progress in hepatology. Drug induced chronic liver disease. Gastroenterology 1977; 72: 1348–53
- Lockhart J DF, Masheter H C. Report of a multicentre* monitored release study of perhexiline maleate in the prevention of angina pectoris. Br J Clin Pract 1976; 30: 172–7
- Lageron A, Levy V G, Lecomte D, de Saint-Maur P P. Hepatic ganglioside excess after perhexihline maleate. Morphological and biochemical evolution (Fr.). Nouv Presse Med 1977; 6: 2859–64
- Garson W P, Gulin R C, Pheor D N. Clinical experience with perhexiline maleate in forty-six patients with angina. Post Grad Med J 1973; 49(suppl 3)90–2
- McDonald G SA. Liver damage after perhexiline maleate. Lancet 1977; 1: 1056
- Galambos J T. Natural history of alcoholic hepatitis. 111. Histological changes. Gastroenterology 1972; 63: 1026–35
- Lageron A, Poupon R, de Saint-Maur P P, Levy V G. Liver ganglioside storage after perhexiline maleate. Lancet 1977; 1(26)483
- Lullmann H, Lullmann-Rauch R, Wassermann O. Drug-induced phospholipidosis. CRC Crit Rev Toxicology 1975; 4: 185–218